SCINAI IMMUNOTHERAPEUTICS LTD. Dilutive Share Adjustment
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Dilutive Share Adjustment of 1.30 billion shares for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2023-05-15
- SCINAI IMMUNOTHERAPEUTICS LTD. weighted average number diluted shares outstanding adjustment for the quarter ending 2023-03-31 was 1.30B shares, a 73.93% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. weighted average number diluted shares outstanding adjustment for the quarter ending 2022-03-31 was 744.71M shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month |
|---|---|
| 2023-03-31 | 1.30B shares 10-Q · filed 2023-05-15 |
| 2022-03-31 | 744.71M shares 10-Q · filed 2023-05-15 |